Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

452.27 +7.07 (+1.59%)
Streaming Delayed Price Updated: 2:08 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 576,587
Open 445.50
Bid (Size) 452.04 (2)
Ask (Size) 452.77 (1)
Prev. Close 445.20
Today's Range 443.49 - 456.97
52wk Range 377.85 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EU
Vertex announced on Tuesday that eligible patients in Ireland, Denmark, and Germany will have access to Alyftrek shortly after receiving regulatory approval from the relevant authorities. 
Via Stocktwits
$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
Via Benzinga

Performance

YTD
+11.5%
+11.5%
1 Month
+1.5%
+1.5%
3 Month
-6.7%
-6.7%
6 Month
+13.3%
+13.3%
1 Year
-4.0%
-4.0%

More News

Read More
How Do Investors Really Feel About Vertex Pharmaceuticals?
Via Benzinga
3 S&P 500 Stocks with Mounting Challenges
Via StockStory
Topics Artificial Intelligence Stocks
Vertex Pharmaceuticals Unusual Options Activity
Via Benzinga
What's Driving the Market Sentiment Around Vertex Pharmaceuticals?
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Unpopular Stocks Facing Headwinds
Via StockStory
Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions
From Vertex Pharmaceuticals Incorporated
Via Business Wire
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
Via Benzinga
Friday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
2 Growth Stocks to Buy and Hold for 10 Years
Via The Motley Fool
Topics Artificial Intelligence Economy World Trade
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts
Via Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool
$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
Via Benzinga
1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore
Via StockStory
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It
Via Benzinga
Topics Artificial Intelligence
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 No-Brainer Healthcare Stocks to Buy in June
Via The Motley Fool
4 Monster Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
Topics Artificial Intelligence World Trade
2 Top Stocks to Buy Right Now
Via The Motley Fool
Topics Economy
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Via The Motley Fool
Topics Economy Government Law Enforcement
3 Top Growth Stocks to Buy in the Second Half of 2025
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
2 Monster Growth Stocks to Buy and Hold for 10 Years
Via The Motley Fool
Topics Bankruptcy

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 452.27
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 07/01/25 02:08 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 117.33B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 117B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.